Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hiPSC-RPEs Transplantation for Advanced Age-Related Macular Degeneration
NCT07418177Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in age-related macular degeneration (AMD), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence and Severity of Treatment-Related Adverse Events at 2 years. Started Oct 2025; status: recruiting.
02
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT07418177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418177.